Shanghai Kaikai Industrial Co., Ltd. Class A

Shanghai Kaikai Industrial Co., Ltd. Class A

11.78
CNY
-0.45
(-3.68%)
0.14EPS
138.25P/E
3.94BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
3.38
3.64
3.55
3.83
3.97
3.49
3.56
3.34
2.78
3.58
3.77
4.38
4.38
4.53
Basic EPS, GAAP
0.1
0.15
0.08
0.09
0.16
0.14
0.09
0.06
0.09
0.16
0.16
0.14
0.05
0.11
Free Cash Flow per Basic Share
-0.1
0.08
0.03
0.04
0.17
0.12
0.07
0.33
-0.89
0.3
-0.03
-0.32
0.55
- -
Dividend per Share
0.02
0.04
0.04
0.03
0.03
0.05
0.04
0.03
0.02
0.03
0.05
0.05
0.04
0.02
Book Value per Share
1.56
1.68
2.1
2.01
2.04
2.04
2.12
2.12
2.2
2.34
2.45
2.55
2.96
3.09
Tangible Book Value per Share
1.56
1.68
2.1
2.01
2.04
2.04
2.11
2.12
2.19
2.33
2.44
2.52
2.94
3.08
Basic Weighted Avg Shares
254
242
248
237
242
252
244
228
241
250
246
250
259
262
Sales/Revenue/Turnover
859
883
881
906
962
878
870
762
670
894
925
1,094
1,132
1,188
Operating Margin (%)
2.82
0.98
2.37
2.29
4.4
4.56
3.13
3.12
3.56
4.88
3.62
3.24
3.19
2.65
Depreciation Expense
12
13
13
13
14
14
15
16
29
31
31
31
32
- -
Net Income, GAAP
25
36
20
21
39
35
22
14
22
40
39
35
13
28
Effective Tax Rate (%)
29.47
21.63
38.22
36.57
23.24
24.43
34.28
43.46
33.5
34.03
25.36
28.21
27.68
16.16
Profit Margin (%)
2.96
4.12
2.25
2.35
4.03
4.01
2.52
1.8
3.24
4.47
4.25
3.2
1.14
2.4
Working Capital
42
74
111
129
218
243
247
251
109
154
196
241
423
433
LT Debt
- -
- -
- -
- -
- -
- -
- -
20
13
5
3
5
6
4
Total Equity
388
415
518
494
502
501
520
520
547
578
607
649
821
813
Return on Invested Capital (%)
14.62
18.97
5.61
6.55
15.9
14.36
8.92
4.77
5.38
10.86
11.33
13.04
5.3
- -
Return on Capital (%)
6.62
8.97
2.33
2.19
10.19
5.22
4.36
2.7
5.03
6.75
6.1
3.54
-0.05
- -
Return on Common Equity (%)
7.06
9.24
4.32
4.26
7.87
7.11
4.35
2.65
4.13
7.23
6.75
5.76
1.85
- -

Capital Structure

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
19
18
17
LT Borrowings
- -
- -
- -
LT Finance Leases
4
3
4
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
263
263
263
Market Capitalization
3,349
2,663
3,942

Working Capital

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
1,222
1,230
1,257
Cash, Cash Equivalents & STI
515
546
512
Accounts Receivable, Net
615
604
657
Inventories
78
71
77
Total Current Liabilities
768
767
824
Payables & Accruals
- -
- -
- -
ST Debt
19
18
17
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
4.98%
9.83%
26.44%
Free Cash Flow
84.36%
34.62%
-278.78%
Net Income, GAAP
7.19%
13.43%
-63.03%
Sales/Revenue/Turnover
3.36%
9.33%
3.52%
Total Cash Common Dividend
9.54%
19.76%
-10.19%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
234
255
255
349
1,094
2025
270
274
- -
307
1,132
2026
269
305
306
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.1
0.03
0.01
- -
0.14
2025
0.03
0.02
- -
- -
0.05
2026
0.07
0.02
0.02
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
0.05
- -
0.05
2025
- -
0.04
- -
- -
0.04
2026
- -
- -
0.02
- -
- -

Company Description

CEO
Guang Jing Liu
Full Time Employees
438
Sector
Consumer non-durables
Industry
Apparel/Footwear
Address
No. 678 Changping Road Shanghai SH China 200040
IPO Date
Feb 28, 2001
Business
Shanghai Kai Kai Industry Company Limited (600272.SS) engages in the production, wholesale, and retail of pharmaceutical and apparel products primarily in China. The company operates dual core businesses in pharmaceuticals and clothing; its pharmaceutical segment offers proprietary Chinese and Western medicines, Chinese medicine tablets and patent preparations under the Jing and Que brands, medical consumables, reagents, and medical devices, alongside wholesale and retail of traditional Chinese and Western medicines, diagnosis and treatment services under the Shang Lei and Yunshang Life brands, and customized processing services for ointment formulations; its apparel segment provides shirts, wool and velvet shirts, sweaters, cardigans, and clothing series under the Kai Kai brand, as well as school uniforms under the Mangnessen brand. Founded in 1992 and listed on the Shanghai Stock Exchange in 2001, the company is headquartered in Shanghai, China, and targets healthcare providers, retailers, and consumers across domestic markets. Recent honors include certification of the Kaikai Silk Scarf series as a Shanghai Gift brand product, recognition of Kaikai as Shanghai's First Economic Leading Brand, and designation of its Customized Processing Service for Ointment Formulations as the sole traditional Chinese medicine service in the Shanghai Brand certification.